The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft

Ryuichi Suemitsu, Ichiro Yoshino, Fumihiro Shoji, Masafumi Yamaguchi, Yukihiro Tomita, Yoshihiko Maehara

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Obliterative bronchiolitis is a major clinical problem in cases involving a transplanted lung. We examined drug-induced tolerance to a fully allogenic tracheal graft in a murine heterotopic transplantation model. Recipient mice (C57BL/6) were primed iv with 1 × 10 8 splenocytes of donor mice (BALB/c). Day 0 was the day of the splenocyte injection. Cyclophosphamide and Busulfan were injected intraperitoneally on day 2. On day 3, 1 × 10 7 donor bone marrow cells were intravenously injected. On day 28, a donor tracheal graft was implanted into a subcutaneous pocket. Grafts were harvested at 3-week intervals, and the degree of obstruction of the inner cavity, the condition of epithelium, and the viability of chondrocytes were examined. All of the isograft controls (BALB/c) and grafts implanted in the T cell-free recipients (BALB/c-nu) showed patent, lined epithelium and viable chondrocytes. All allografts tested showed total luminal occlusion by granulative tissue and inflammatory cells, and the epithelium was totally absent. Five of 11 drug-treated grafts were completely patent, although the epithelium was almost absent and the chondrocytes were substantially destroyed. However, when the chimerism was analyzed by flow cytometry analysis of the recipient T cells, approximately 90% of the donor cells were recognized. Even by this pre-treatment-induced chimerism, a transplanted allogenic trachea was not completely preserved. The present results suggest that a non-allogenic response might have contributed to the rejection.

Original languageEnglish
Pages (from-to)8-13
Number of pages6
JournalJournal of Surgical Research
Volume122
Issue number1
DOIs
Publication statusPublished - Nov 1 2004

Fingerprint

Immunosuppressive Agents
Transplants
Antigens
Epithelium
Chondrocytes
Chimerism
Heterotopic Transplantation
Isografts
Drug Tolerance
T-Lymphocytes
Busulfan
Bronchiolitis
Trachea
Inbred C57BL Mouse
Bone Marrow Cells
Cyclophosphamide
Allografts
Flow Cytometry
Lung
Injections

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft. / Suemitsu, Ryuichi; Yoshino, Ichiro; Shoji, Fumihiro; Yamaguchi, Masafumi; Tomita, Yukihiro; Maehara, Yoshihiko.

In: Journal of Surgical Research, Vol. 122, No. 1, 01.11.2004, p. 8-13.

Research output: Contribution to journalArticle

Suemitsu, Ryuichi ; Yoshino, Ichiro ; Shoji, Fumihiro ; Yamaguchi, Masafumi ; Tomita, Yukihiro ; Maehara, Yoshihiko. / The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft. In: Journal of Surgical Research. 2004 ; Vol. 122, No. 1. pp. 8-13.
@article{edf37b18287d4800aa1257f645041e2b,
title = "The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft",
abstract = "Obliterative bronchiolitis is a major clinical problem in cases involving a transplanted lung. We examined drug-induced tolerance to a fully allogenic tracheal graft in a murine heterotopic transplantation model. Recipient mice (C57BL/6) were primed iv with 1 × 10 8 splenocytes of donor mice (BALB/c). Day 0 was the day of the splenocyte injection. Cyclophosphamide and Busulfan were injected intraperitoneally on day 2. On day 3, 1 × 10 7 donor bone marrow cells were intravenously injected. On day 28, a donor tracheal graft was implanted into a subcutaneous pocket. Grafts were harvested at 3-week intervals, and the degree of obstruction of the inner cavity, the condition of epithelium, and the viability of chondrocytes were examined. All of the isograft controls (BALB/c) and grafts implanted in the T cell-free recipients (BALB/c-nu) showed patent, lined epithelium and viable chondrocytes. All allografts tested showed total luminal occlusion by granulative tissue and inflammatory cells, and the epithelium was totally absent. Five of 11 drug-treated grafts were completely patent, although the epithelium was almost absent and the chondrocytes were substantially destroyed. However, when the chimerism was analyzed by flow cytometry analysis of the recipient T cells, approximately 90{\%} of the donor cells were recognized. Even by this pre-treatment-induced chimerism, a transplanted allogenic trachea was not completely preserved. The present results suggest that a non-allogenic response might have contributed to the rejection.",
author = "Ryuichi Suemitsu and Ichiro Yoshino and Fumihiro Shoji and Masafumi Yamaguchi and Yukihiro Tomita and Yoshihiko Maehara",
year = "2004",
month = "11",
day = "1",
doi = "10.1016/j.jss.2004.04.019",
language = "English",
volume = "122",
pages = "8--13",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft

AU - Suemitsu, Ryuichi

AU - Yoshino, Ichiro

AU - Shoji, Fumihiro

AU - Yamaguchi, Masafumi

AU - Tomita, Yukihiro

AU - Maehara, Yoshihiko

PY - 2004/11/1

Y1 - 2004/11/1

N2 - Obliterative bronchiolitis is a major clinical problem in cases involving a transplanted lung. We examined drug-induced tolerance to a fully allogenic tracheal graft in a murine heterotopic transplantation model. Recipient mice (C57BL/6) were primed iv with 1 × 10 8 splenocytes of donor mice (BALB/c). Day 0 was the day of the splenocyte injection. Cyclophosphamide and Busulfan were injected intraperitoneally on day 2. On day 3, 1 × 10 7 donor bone marrow cells were intravenously injected. On day 28, a donor tracheal graft was implanted into a subcutaneous pocket. Grafts were harvested at 3-week intervals, and the degree of obstruction of the inner cavity, the condition of epithelium, and the viability of chondrocytes were examined. All of the isograft controls (BALB/c) and grafts implanted in the T cell-free recipients (BALB/c-nu) showed patent, lined epithelium and viable chondrocytes. All allografts tested showed total luminal occlusion by granulative tissue and inflammatory cells, and the epithelium was totally absent. Five of 11 drug-treated grafts were completely patent, although the epithelium was almost absent and the chondrocytes were substantially destroyed. However, when the chimerism was analyzed by flow cytometry analysis of the recipient T cells, approximately 90% of the donor cells were recognized. Even by this pre-treatment-induced chimerism, a transplanted allogenic trachea was not completely preserved. The present results suggest that a non-allogenic response might have contributed to the rejection.

AB - Obliterative bronchiolitis is a major clinical problem in cases involving a transplanted lung. We examined drug-induced tolerance to a fully allogenic tracheal graft in a murine heterotopic transplantation model. Recipient mice (C57BL/6) were primed iv with 1 × 10 8 splenocytes of donor mice (BALB/c). Day 0 was the day of the splenocyte injection. Cyclophosphamide and Busulfan were injected intraperitoneally on day 2. On day 3, 1 × 10 7 donor bone marrow cells were intravenously injected. On day 28, a donor tracheal graft was implanted into a subcutaneous pocket. Grafts were harvested at 3-week intervals, and the degree of obstruction of the inner cavity, the condition of epithelium, and the viability of chondrocytes were examined. All of the isograft controls (BALB/c) and grafts implanted in the T cell-free recipients (BALB/c-nu) showed patent, lined epithelium and viable chondrocytes. All allografts tested showed total luminal occlusion by granulative tissue and inflammatory cells, and the epithelium was totally absent. Five of 11 drug-treated grafts were completely patent, although the epithelium was almost absent and the chondrocytes were substantially destroyed. However, when the chimerism was analyzed by flow cytometry analysis of the recipient T cells, approximately 90% of the donor cells were recognized. Even by this pre-treatment-induced chimerism, a transplanted allogenic trachea was not completely preserved. The present results suggest that a non-allogenic response might have contributed to the rejection.

UR - http://www.scopus.com/inward/record.url?scp=7444227433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7444227433&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2004.04.019

DO - 10.1016/j.jss.2004.04.019

M3 - Article

C2 - 15522308

AN - SCOPUS:7444227433

VL - 122

SP - 8

EP - 13

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -